PULMATRIX INC (PULM) Fundamental Analysis & Valuation
NASDAQ:PULM • US74584P3010
Current stock price
2.11 USD
-0.05 (-2.31%)
Last:
This PULM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. PULM Profitability Analysis
1.1 Basic Checks
- PULM had negative earnings in the past year.
- PULM had a negative operating cash flow in the past year.
- PULM had negative earnings in each of the past 5 years.
- In the past 5 years PULM always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of PULM (-124.85%) is worse than 79.79% of its industry peers.
- PULM has a worse Return On Equity (-131.42%) than 66.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -124.85% | ||
| ROE | -131.42% | ||
| ROIC | N/A |
ROA(3y)-61.24%
ROA(5y)-54.83%
ROE(3y)-81.96%
ROE(5y)-75.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for PULM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. PULM Health Analysis
2.1 Basic Checks
- PULM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, PULM has about the same amount of shares outstanding.
- PULM has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for PULM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- PULM has an Altman-Z score of -68.67. This is a bad value and indicates that PULM is not financially healthy and even has some risk of bankruptcy.
- PULM has a Altman-Z score of -68.67. This is amonst the worse of the industry: PULM underperforms 92.23% of its industry peers.
- There is no outstanding debt for PULM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -68.67 |
ROIC/WACCN/A
WACC9.49%
2.3 Liquidity
- PULM has a Current Ratio of 19.97. This indicates that PULM is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of PULM (19.97) is better than 90.67% of its industry peers.
- PULM has a Quick Ratio of 19.97. This indicates that PULM is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 19.97, PULM belongs to the best of the industry, outperforming 90.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 19.97 | ||
| Quick Ratio | 19.97 |
3. PULM Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 35.59% over the past year.
- PULM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.97%.
- PULM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.26% yearly.
EPS 1Y (TTM)35.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.1%
Revenue 1Y (TTM)-99.97%
Revenue growth 3Y14.72%
Revenue growth 5Y-0.26%
Sales Q2Q%-100%
3.2 Future
- Based on estimates for the next years, PULM will show a very strong growth in Earnings Per Share. The EPS will grow by 23.43% on average per year.
- The Revenue is expected to grow by 43.66% on average over the next years. This is a very strong growth
EPS Next Y-10%
EPS Next 2Y22.57%
EPS Next 3Y28.64%
EPS Next 5Y23.43%
Revenue Next Year1%
Revenue Next 2Y54.02%
Revenue Next 3Y58.32%
Revenue Next 5Y43.66%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. PULM Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for PULM. In the last year negative earnings were reported.
- Also next year PULM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as PULM's earnings are expected to grow with 28.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.57%
EPS Next 3Y28.64%
5. PULM Dividend Analysis
5.1 Amount
- No dividends for PULM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PULM Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:PULM (3/13/2026, 8:00:00 PM)
2.11
-0.05 (-2.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-16 2025-10-16
Earnings (Next)03-26 2026-03-26/bmo
Inst Owners9.77%
Inst Owner Change2.77%
Ins Owners0.66%
Ins Owner Change0%
Market Cap7.70M
Revenue(TTM)3.00K
Net Income(TTM)-6.22M
Analysts82.86
Price TargetN/A
Short Float %0.12%
Short Ratio0.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2567.17 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.63 | ||
| P/tB | 1.63 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.7
EYN/A
EPS(NY)-2.28
Fwd EYN/A
FCF(TTM)-1.64
FCFYN/A
OCF(TTM)-1.64
OCFYN/A
SpS0
BVpS1.3
TBVpS1.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -124.85% | ||
| ROE | -131.42% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-61.24%
ROA(5y)-54.83%
ROE(3y)-81.96%
ROE(5y)-75.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 19.97 | ||
| Quick Ratio | 19.97 | ||
| Altman-Z | -68.67 |
F-Score3
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)312.07%
Cap/Depr(5y)229.17%
Cap/Sales(3y)5.28%
Cap/Sales(5y)4.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.1%
EPS Next Y-10%
EPS Next 2Y22.57%
EPS Next 3Y28.64%
EPS Next 5Y23.43%
Revenue 1Y (TTM)-99.97%
Revenue growth 3Y14.72%
Revenue growth 5Y-0.26%
Sales Q2Q%-100%
Revenue Next Year1%
Revenue Next 2Y54.02%
Revenue Next 3Y58.32%
Revenue Next 5Y43.66%
EBIT growth 1Y16.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y69.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.52%
OCF growth 3YN/A
OCF growth 5YN/A
PULMATRIX INC / PULM Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for PULMATRIX INC?
ChartMill assigns a fundamental rating of 3 / 10 to PULM.
Can you provide the valuation status for PULMATRIX INC?
ChartMill assigns a valuation rating of 1 / 10 to PULMATRIX INC (PULM). This can be considered as Overvalued.
How profitable is PULMATRIX INC (PULM) stock?
PULMATRIX INC (PULM) has a profitability rating of 0 / 10.
What is the financial health of PULMATRIX INC (PULM) stock?
The financial health rating of PULMATRIX INC (PULM) is 7 / 10.
Can you provide the expected EPS growth for PULM stock?
The Earnings per Share (EPS) of PULMATRIX INC (PULM) is expected to decline by -10% in the next year.